X4 Pharmaceuticals (XFOR) Earnings Per Share (EPS)
Market Cap: $33.00M
Avg Volume: 3.29M
Industry: Biotechnology
Sector: Healthcare
Earnings Per Share (EPS) Summary (Annual)
According to X4 Pharmaceuticals's latest annual financial reports, the company has an earnings per share (EPS) of $-0.19 and a diluted EPS of $-0.19. The EPS indicates the portion of a company's profit allocated to each outstanding share of common stock, serving as an indicator of a company's profitability.
The company's EPS growth rate stands at 66.67%, and the diluted EPS growth rate is 66.67%. These metrics reflect the annual growth rate of earnings per share and diluted earnings per share over the specified period.
EPS
$-0.19
Diluted EPS
$-0.19
EPS Growth
66.67%
X4 Pharmaceuticals Historical EPS
X4 Pharmaceuticals Historical EPS Growth
EPS History
The table below shows the EPS for each year, with the latest data available for the last fiscal year 2024.
| Year | EPS | Change |
|---|---|---|
| 2024 | $-0.19 | 66.67% |
| 2023 | $-0.57 | 61.49% |
| 2022 | $-1.48 | 56.98% |
| 2021 | $-3.44 | -11.33% |
| 2020 | $-3.09 | 37.07% |
| 2019 | $-4.91 | 94.76% |
| 2018 | $-93.73 | 4.92% |
| 2017 | $-98.58 | -298.14% |
| 2016 | $-24.76 | -73.88% |
| 2015 | $-14.24 | 0.00% |
Related Metrics
Explore detailed financial metrics and analysis for XFOR.